Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,500 | |||
10 mg | 在庫あり | ¥ 17,500 | |||
25 mg | 在庫あり | ¥ 29,500 | |||
50 mg | 在庫あり | ¥ 44,000 | |||
100 mg | 在庫あり | ¥ 66,000 | |||
200 mg | 在庫あり | ¥ 99,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 19,000 |
説明 | ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma. |
別名 | VML530, VML-530, VML 530, ABT080 |
分子量 | 590.64 |
分子式 | C37H31N2NaO4 |
CAS No. | 189498-57-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (84.51 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABT-080 189498-57-5 GPCR/G Protein Leukotriene Receptor VML530 ABT 080 VML-530 VML 530 ABT080 Inhibitor inhibitor inhibit